Search - tctmd.com

Displaying 321 - 340 of 480

Sort: Relevancy | Date

Presentation TCT 2015

TCT 53: Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Intracranial Bleeding Results From the Amplatzer Cardiac Plug Registry

Presenter: Jacqueline Saw, Steven J. Yakubov, Apostolos Tzikas

October 13, 2015

Presentation TCT 2015

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Presenter: George D. Dangas, Paul A. Gurbel, C. Michael Gibson

October 13, 2015

Presentation TCT 2015

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Uwe Zeymer

October 11, 2015

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

Presentation

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Presenter: R. Chopard

August 27, 2015

Presentation

Use and Outcomes of Triple Therapy Among Older Patients With Acute MI and A-fib

Presenter: Connie N. Hess

August 03, 2015

Presentation

Perioperative Bridging Anticoagulation in Patients With A-fib

Presenter: JD. Douketis

July 09, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation

A-fib and Risk of STEMI vs NSTEMI

Presenter: Elsayed Z. Soliman

May 06, 2015

Presentation

Prognosis of Silent A-fib After Acute MI at 1 Year

Presenter: K. Stamboul

April 30, 2015

Presentation ECHO 2015

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Presenter: Fletcher A. Miller

April 26, 2015

Presentation

Oral Anticoagulant Prescription in Patients With A-fib and Low Risk of Thromboembolism

Presenter: J.C. Hsu

April 23, 2015

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Presenter: AO Badheka

December 11, 2014

Presentation

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Presenter: Nissen Bonde

December 08, 2014

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Presentation

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Presenter: G. Santoro

November 05, 2014

Presentation

Risk of Bleeding With Dabigatran in A-fib

Presenter: I. Hernandez

November 04, 2014

Presentation Cardiovascular Interventions 2014

Left Atrial Appendage Closure for Atrial Fibrillation

Presenter: Matthew J. Price

October 23, 2014

Presentation

Atrial Fibrillation, Stroke, and Mortality Rates Following TAVI

Presenter: Lior Yankelson

October 13, 2014

Advertisement

TCT 53: Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Intracranial Bleeding Results From the Amplatzer Cardiac Plug Registry

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Outcome of Patients With Atrial Fibrillation and Stent Implantation: Results of the Prospective LASER Registry

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Baseline Characteristics and Prognostic Implications of Preexisting and New-Onset A-fib After TAVR

Use and Outcomes of Triple Therapy Among Older Patients With Acute MI and A-fib

Perioperative Bridging Anticoagulation in Patients With A-fib

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

A-fib and Risk of STEMI vs NSTEMI

Prognosis of Silent A-fib After Acute MI at 1 Year

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Oral Anticoagulant Prescription in Patients With A-fib and Low Risk of Thromboembolism

LAA Occlusion for Stroke Prevention in A-Fib

Utilization and Adverse Outcomes of Percutaneous LAA Closure for Stroke Prevention in A-fib in the US

Net Clinical Benefit of Antithrombotic Therapy in Patients With A-fib and Chronic Kidney Disease

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Percutaneous LAA Occlusion in Patients With Nonvalvular A-fib

Risk of Bleeding With Dabigatran in A-fib

Left Atrial Appendage Closure for Atrial Fibrillation

Atrial Fibrillation, Stroke, and Mortality Rates Following TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content